Much research has focused on the responses to microbial products of immune cells such as monocytes, macrophages, and neutrophils. Although the liver is a primary response organ in various infections, relatively little is known about the antimicrobial responses of its major cell type, the hepatocyte. It is now known that the recognition of bacteria occurs via cell-surface proteins that are members of the Toll-like receptor (TLR) family. In addition, lipopolysaccharide (LPS) is bound by circulating LPS-binding protein (LBP) and presented to cell-surface CD14, which in turn interacts with TLR and transduces an intracellular signal. We investigated the CD14 and TLR2 responses of whole liver and isolated hepatocytes, and demonstrated that these cells can be induced to express the molecules necessary for responses to both Gram-positive and Gram-negative bacteria. Our findings may have clinical implications for pathological states such as sepsis.
References
1.
Angus DC, Linde-Zwirble WT, Lidicker J.et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med2001; 29: 1303—1310.
2.
Sriskandan S. , Cohen J.Gram-positive sepsis. Mechanisms and differences from Gram-negative sepsis. Infect Dis Clin North Am1999; 13: 397—412.
3.
Medzhitov R. , Janeway Jr CJ. Innate immunity. N Engl J Med2000; 343: 338—344.
4.
Panaro MA, Mitolo V.Cellular responses to FMLP challenging: a mini-review. Immunopharmacol Immunotoxicol1999; 21: 397—419.
5.
Krieg AMCpG oligonucleotides as immune adjuvants. Ernst Schering Res Found Workshop2000; 105—118.
6.
Means TK, Golenbock DT, Fenton MJThe biology of Toll-like receptors. Cytokine Growth Factor Rev2000; 11: 219—232.
7.
Pastor CM, Billiar TRRegulation and functions of nitric oxide in the liver in sepsis and inflammation . New Horizons1995; 3: 65—72.
8.
Johnson ML, Billiar TRRoles of nitric oxide in surgical infection and sepsis. World J Surg1998; 22: 187—196.
9.
Hassett DJ, Cohen MSBacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J1989; 3: 2574—2582.
10.
Ruiter DJ, van der Meulen J., Brouwer A. et al. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest1981; 45: 38—45.
11.
Kimura H., Takizawa N., Nozaki N. et al. Molecular cloning of cDNA encoding mouse CDC21 and CDC46 homologs and characterization of the products: physical interaction between P1(MCM3) and CDC46 proteins. Nucleic Acids Res1995 ; 23: 2097—2104.
12.
Maitra SK, Rachmilewitz D., Eberle D. et al. The hepatocellular uptake and biliary excretion of endotoxin in the rat. Hepatology1981; 1: 401—407.
13.
Fox ES, Thomas P., Broitman SAUptake and modification of 125I-lipopolysaccharide by isolated rat Kupffer cells. Hepatology1988; 8: 1550—1554.
14.
Treon SP, Thomas P., Broitman SALipopolysaccharide (LPS) processing by Kupffer cells releases a modified LPS with increased hepatocyte binding and decreased tumor necrosis factor-alpha stimulatory capacity. Proc Soc Exp Biol Med1993; 202: 153—158.
15.
Fox ES, Thomas P., Broitman SAClearance of gut-derived endotoxins by the liver. Release and modification of 3H, 14C-lipopolysaccharide by isolated rat Kupffer cells. Gastroenterology1989; 96: 456—461.
16.
Mimura Y., Sakisaka S., Harada M. et al. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology1995; 109: 1969—1976.
17.
Zlydaszyk JC , Moon RJFate of 51Cr-labeled lipopolysaccharide in tissue culture cells and livers of normal mice. Infect Immun1976; 14: 100—105.
18.
Ghermay AP, Brady S., Havel RJ et al. Sepsis increases endocytosis of endotoxin into hepatocytes. Surgery1996; 120: 389—393.
19.
Geppert TD, Whitehurst CE, Thompson P. et al. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol Med1994; 1: 93—103.
20.
Madine MA, Khoo CY, Mills AD et al. MCM3 complex required for cell cycle regulation of DNA replication in vertebrate cells [see comments]. Nature1995; 375: 421—424.
21.
Thompson LH , West MGXRCC1 keeps DNA from getting stranded. Mutat Res2000; 459: 1—18.
22.
Moir D., Stewart SE, Osmond BC et al. Cold-sensitive cell-division-cycle mutants of yeast: isolation, properties, and pseudoreversion studies. Genetics1982; 100: 547—563.
23.
Moller P., Wallin H., Dybdahl M. et al. Psoriasis patients with basal cell carcinoma have more repair-mediated DNA strand-breaks after UVC damage in lymphocytes than psoriasis patients without basal cell carcinoma. Cancer Lett2000; 151: 187—192.
24.
Fang-Kircher SG, Labudova O., Kitzmueller E. et al. Increased steady state mRNA levels of DNA-repair genes XRCC1, ERCC2 and ERCC3 in brain of patients with Down syndrome. Life Sci1999; 64: 1689—1699.
25.
Liu S., Khemlani LS, Shapiro RA et al. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect Immun1998; 66: 5089—5098.
26.
Liu S., Shapiro RA, Nie S. et al. Characterization of rat CD14 promoter and its regulation by transcription factors AP-1 and Sp family proteins in hepatocytes. Gene2000; 250: 137—147.
27.
West MA, Keller GA, Cerra FB et al. Killed Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis. Infect Immun1985 ; 49: 563—570.
28.
Curran RD, Billiar TR, Stuehr DJ et al. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med1989; 170: 1769—1774.
29.
Fearns C., Kravchenko VV, Ulevitch RJ et al. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med1995; 181: 857—866.
30.
Hetherington CJ, Kingsley PD, Crocicchio F. et al. Characterization of human endotoxin lipopolysaccharide receptor CD14 expression in transgenic mice. J Immunol1999; 162: 503—509.
31.
Liu S., Salyapongse AN, Geller DA et al. Hepatocyte toll-like receptor 2 expression in vivo and in vitro: role of cytokines in induction of rat TLR2 gene expression by lipopolysaccharide . Shock2000; 14: 361—365.
32.
Cano E., Mahadevan LCParallel signal processing among mammalian MAPKs. Trends Biochem Sci1995; 20: 117—122.
Raingeaud J. , Gupta S., Rogers JS et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen- activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem1995 ; 270: 7420—7426.
35.
Karin M., Hunter T.Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol1995; 5: 747—757.
36.
Liu MK, Herrera-Velit P., Brownsey RW et al. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide . J Immunol1994; 153: 2642—2652.
37.
Lee JC, Laydon JT, McDonnell PC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature1994; 372: 739—746.
38.
Hambleton J. , McMahon M., DeFranco ALActivation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. J Exp Med1995; 182: 147—154.
39.
Weinstein SL, Gold MR, DeFranco ALBacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA1991; 88: 4148—4152.
40.
Geppert TD, Whitehurst CE, Thompson P. et al. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol Med1994; 1: 93—103.
41.
Reimann T., Buscher D., Hipskind RA et al. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes. J Immunol1994; 153: 5740—5749.
42.
Hambleton J., Weinstein SL, Lem L. et al. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide- stimulated macrophages. Proc Natl Acad Sci USA1996; 93: 2774—2778.
43.
Perregaux DG, Dean D., Cronan M. et al. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence. Mol Pharmacol1995; 48: 433—442.
44.
Robertson LM , Kerppola TK, Vendrell M. et al. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron1995; 14: 241—252.
45.
Janknecht R. , Hunter T.Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J1997 ; 16: 1620—1627.
46.
Whitmarsh AJ , Yang SH, Su MS et al. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol1997; 17: 2360—2371.
47.
Price MA, Cruzalegui FH, Treisman R.The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J1996; 15: 6552—6563.
48.
Derijard B. , Hibi M., Wu IH et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain . Cell1994; 76: 1025—1037.
49.
Hirschfeld M., Kirschning CJ, Schwandner R. et al. Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol1999; 163: 2382—2386.
50.
Jackson DE, Howlett CR, Wicken AJ et al. Induction of hypersensitivity reactions to Lactobacillus fermentum and lipoteichoic acid in rabbits. Part II. Int Arch Allergy Appl Immunol1981; 65: 304—312.
51.
Hummell DS, Winkelstein JABacterial lipoteichoic acid sensitizes host cells for destruction by autologous complement. J Clin Invest1986; 77: 1533—1538.
52.
Ohshima Y., Beuth J., Ko HL et al. Immunomodulatory effects of staphylococcal lipoteichoic acid in early Listeria monocytogenes infection in Balb/c-mice. Zentralbl Bakteriol Mikrobiol Hyg [A]1988; 269: 251—256.
53.
Quale JM, Mandel LJ, Bergasa NV et al. Clinical significance and pathogenesis of hyperbilirubinemia associated with Staphylococcus aureus septicemia. Am J Med1988; 85: 615—618.
54.
Wakabayashi G., Gelfand JA, Jung WK et al. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J Clin Invest1991; 87: 1925—1935.
55.
Hyzy J., Sciotti V., Albini B. et al. Deposition of circulating streptococcal lipoteichoic acid in mouse tissues. Microb Pathog1992; 13: 123—132.
56.
Nonogaki K. , Moser AH, Pan XM et al. Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo. J Lipid Res1995; 36: 1987—1995.
57.
De Kimpe SJ , Kengatharan M., Thiemermann C. et al. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA1995; 92: 10359—10363.
58.
Kengatharan KM, DeKimpe SJ, Thiemermann C. Role of nitric oxide in the circulatory failure and organ injury in a rodent model of Gram-positive shock. Br J Pharmacol1996; 119: 1411—1421.
59.
Courtney HS , Ofek I., Hasty DLM protein mediated adhesion of M type 24 Streptococcus pyogenes stimulates release of interleukin-6 by HEp-2 tissue culture cells . FEMS Microbiol Lett1997; 151: 65—70.
60.
Bucher M., Ittner KP, Zimmermann M. et al. Nitric oxide synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipoteichoic acid. FEBS Lett1997; 412: 511—514.
61.
Zacharowski K., Frank S., Otto M. et al. Lipoteichoic acid induces delayed protection in the rat heart: a comparison with endotoxin. Arterioscler Thromb Vasc Biol2000; 20: 1521—1528.
62.
Zacharowski K., Olbrich A., Cuzzocrea S. et al. Membrane-permeable radical scavenger, tempol, reduces multiple organ injury in a rodent model of Gram-positive shock [see comments]. Crit Care Med2000; 28: 1953—1961.
63.
Trescec A., Iskric S., Ljevakovic D. et al. The effects of immunomodulating peptidoglycan monomer and muramyl dipeptide on hepatic microsomal UDP-glucuronyltransferase and beta-glucuronidase . Int J Immunopharmacol1987; 9: 371—378.
64.
Gilbart J., Fox A.Elimination of group A streptococcal cell walls from mammalian tissues. Infect Immun1987; 55: 1526—1528.
65.
Sartor RB, Bond TM, Schwab JHSystemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury. Infect Immun1988; 56: 2101—2108.
66.
Nomoto K., Nagaoka M., Yokokura T. et al. Augmentation of resistance of mice to bacterial infection by a polysaccharide-peptidoglycan complex (PSPG) extracted from Lactobacillus casei. Biotherapy1989; 1: 169—177.
67.
Lichtman SN , Keku J., Schwab JH et al. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun1991; 59: 555—562.
68.
Chugh IB, Kansal R., Vinayak VK et al. Protective efficacy of different cell-wall fractions of Mycobacterium tuberculosis. Folia Microbiol (Praha) 1992; 37: 407—412.
69.
Bruyn GA, Zegers BJ, van Furth R.Mechanisms of host defense against infection with Streptococcus pneumoniae . Clin Infect Dis1992; 14: 251—262.
70.
Lichtman SN , Okoruwa EE, Keku J. et al. Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest1992; 90: 1313—1322.
71.
Ladesic B., Perovic S., Hrsak I.Pharmacokinetics of an immunomodulator peptidoglycan monomer in mice after intravenous administration. Int J Immunopharmacol1993; 15: 145—150.
72.
Mara M., Ocenaskova J., Novakova M. et al. Resistance to infection and activation of the monocyto-macrophage system caused by Bacillus firmus and its fractions. Folia Microbiol (Praha) 1994; 39: 147—151.
73.
Ando T., Endo Y., Abe M. et al. Stimulation of the synthesis of histamine and putrescine in mice by a peptidoglycan of Gram-positive bacteria. Microbiol Immunol1994; 38: 209—215.
74.
Sasaki T., Fukami S., Namioka S.Enhanced resistance of mice to Escherichia coli infection induced by administration of peptidoglycan derived from Bifidobacterium thermophilum. J Vet Med Sci1994; 56: 433—437.
75.
Sverko V., Marotti T., Gavella M. et al. Side-effects of peptidoglycan monomer (PGM) treatment in mice . Immunopharmacology1994; 28: 193—199.
76.
Fox ES, Tracy Jr TFAlterations in tumor necrosis factor-alpha expression by hepatic macrophages following acute cholestatic liver injury. Shock1996; 5: 112—115.
77.
Hoijer MA, Melief MJ, Calafat J. et al. Expression and intracellular localization of the human N-acetylmuramyl-L-alanine amidase, a bacterial cell wall-degrading enzyme. Blood1997; 90: 1246—1254.
78.
Dominguez-Rosales JA, Mavi G., Levenson SM et al. H(2)O(2) is an important mediator of physiological and pathological healing responses. Arch Med Res2000; 31: 15—20.
79.
Simelyte E., Rimpilainen M., Lehtonen L. et al. Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains. Infect Immun2000; 68: 3535—3540.
80.
Glatman-Freedman A., Mednick AJ, Lendvai N. et al. Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M. Infect Immun2000; 68: 335—341.
81.
Riley LK, Caffrey CJ, Musille VS et al. Cytotoxicity of Bacillus piliformis. J Med Microbiol1992; 37: 77—80.
82.
Geller DA, Di Silvio M, Nussler AK et al. Nitric oxide synthase expression is induced in hepatocytes in vivo during hepatic inflammation. J Surg Res1993; 55: 427—432.
83.
Seki S., Habu Y., Kawamura T. et al. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev2000; 174: 35—46.
84.
Billiar TR, Maddaus MA, West MA et al. Intestinal Gram-negative bacterial overgrowth in vivo augments the in vitro response of Kupffer cells to endotoxin. Ann Surg1988; 208: 532—540.
85.
Andersson R. , Foss A.Abdominal sepsis following liver resection in the rat. Hepatogastroenterology1991; 38: 547—549.
86.
Grube BJ, Cochane CG, Ye RD et al. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem1994; 269: 8477—8482.
87.
Lichtman SN , Wang J., Zhang C. et al. Endocytosis and Ca2+ are required for endotoxin-stimulated TNF-alpha release by rat Kupffer cells. Am J Physiol1996; 271: G920—G928.
